Investor Relations

Press Releases

 
Press Releases
  Date Title View
Aug 19, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into an agreement to sell its Rare Pediatric Disease Priority Review Voucher (PPRV) to a subsidiary of AbbVie Inc. (NYSE: ABBV). United Therapeutics received the PPRV when UnituxinT...
Aug 17, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 17, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the European Commission (EC) has granted Marketing Authorisation for Unituxin™ (dinutuximab) for the treatment of high-risk neuroblastoma in patients aged 12 months to 17 years, who have previo...
Aug 6, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 6, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the 2015 Wedbush PacGrow Healthcare Conferenc...
Jul 28, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 28, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30, 2015. "Orenitram® sales grew nearly 300% as compared to the second quarter of 2014 when the product was first launched," said Roger ...
Jul 22, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 22, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its second quarter 2015 financial results before market open on Tuesday, July 28, 2015. United Therapeutics will host a half-hour teleconference on Tuesday, July 28, 2015, at 9...
Jun 29, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., June 29, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today the appointment of Dean Judy D. Olian, Ph.D. to its Board of Directors as an independent director.  The appointment is effective as of June 26, 2015. Olian is the dean of the UCLA Anderson School o...
Jun 15, 2015
SILVER SPRING, Md., and RESEARCH TRIANGLE PARK, N.C., June 15, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced receipt of a Paragraph IV Certification Notice Letter from Watson Laboratories, Inc. (Watson) advising that Watson has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Admin...
Jun 15, 2015
JACKSONVILLE, Fla., and SILVER SPRING, Md. - Mayo Clinic in Jacksonville, Florida, and United Therapeutics Corporation (NASDAQ: UTHR) today announced a collaboration to build and operate a lung restoration center on the Mayo ca...
May 29, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., May 29, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the Jefferies 2015 Global Healthcare Conference in...
May 1, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., May 1, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the Deutsche Bank 40th Annual Health Care Conferenc...
1
... NextLast
= add release to Briefcase